topic-orcrp006545 News Coverage on GlaxoSmithKline PLC - CTNow
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 45-55
  • Wealthy nations must follow through on disease fight

    Wealthy nations must follow through on disease fight
    In 1980, I moved my family from Maryland to the White Mountain Apache Reservation in Arizona to work on an issue most people are not comfortable talking about — diarrhea. At the time, diarrhea, which is preventable and treatable, was rampantly...
  • Mailbag: Should they sell seashells at store?

    Perhaps instead of fighting over how many merchants in town sell seashells, they should consider not selling them at all ("Fighting over some seashells," Dave Hansen column, June 2). Yes, I know, they are big sellers, and make money for the merchants....
  • IUDs almost halve risk of cervical cancer: study

    IUDs almost halve risk of cervical cancer: study
    LONDON (Reuters) - Contrary to popular belief, intrauterine contraceptive devices might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease, according to the results of...
  • Genital warts tied to range of cancers

    Genital warts tied to range of cancers
    NEW YORK (Reuters Health) - People who've ever had genital warts may have a somewhat higher risk of several types of cancer — possibly including common skin cancers, a new study suggests. The findings, reported in the Journal of Infectious...
  • Human Genome Sciences rebuffs $2.6 billion offer from GlaxoSmithKline

    Shares of Human Genome Sciences doubled in Thursday morning trading on news that a major British biopharmaceutical company offered to buy it for $2.6 billion, which the Rockville company rejected as too low. Human Genome, which uses the human DNA...
  • Women on the Pill have less menstrual pain

    Women on the Pill have less menstrual pain
    NEW YORK (Reuters Health) - Young women on birth control pills tend to have less painful menstrual periods than those not on the contraceptives, a new study finds. Swedish researchers found that of 2,100 women followed from age 19 to 24, those on the...
  • UK switches to Merck's Gardasil for HPV vaccination

    UK switches to Merck's Gardasil for HPV vaccination
    LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil. The move underscores Gardasil's lead in a $1 billion-plus worldwide...
  • Antidepressants and pregnancy

    Antidepressants and pregnancy
    Upon learning they are pregnant, most women dutifully nix the alcohol, sushi and caffeine. But what about antidepressants? Headlines about the potential risks of antidepressants on a developing fetus, including miscarriage, premature birth and newborn...
  • Group backs HPV shot recommendation for boys

    Group backs HPV shot recommendation for boys
    NEW YORK (Reuters Health) - Boys 11 years and up should get Merck & Co's Gardasil vaccine to protect them against HPV infections, which can cause genital warts as well as oral, penile and anal cancers, the nation's largest group of pediatricians said...
  • Tailored breast cancer drugs in focus at cancer meet

    Tailored breast cancer drugs in focus at cancer meet
    ZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis. Roche's T-DM1 and Novartis's Afinitor...
  • Cancer study boosts hopes for Roche's armed antibody

    Cancer study boosts hopes for Roche's armed antibody
    STOCKHOLM (Reuters) - Women with an aggressive type of advanced breast cancer can live significantly longer without their disease getting worse if they are treated with an experimental "armed antibody" drug from Roche, researchers said on Sunday. Data...